Impact of Vitamin D Treatment on 25 Hydroxy Vitamin D Levels and Insulin Homeostasis in Obese African American Adolescents in a Randomized Trial

Overview

Journal J Clin Transl Endocrinol

Specialty Endocrinology

Date 2018 Jun 13

PMID 29892562

Citations 8

Authors

Usha Sethuraman

Marwan A Zidan

Lynae Hanks

Minoo Bagheri

Ambika Ashraf

Affiliations

Soon will be listed here.

Abstract

Background: Obesity is affecting children in epidemic proportions in the United States with nearly 25% of children being obese. Consequences of obesity including dyslipidemia, type 2 diabetes and cardiovascular disease are leading to morbidity at younger ages. Parallel to the obesity and diabetes epidemics, the prevalence of vitamin D deficiency has reached very high levels and has been associated with insulin resistance and dyslipidemia. Studies exploring the impact of vitamin D repletion on insulin sensitivity and dyslipidemia in children are sparse.The aim of this study was to determine the impact of treatment with vitamin D (ergocalciferol) in obese African American (AA) children on vitamin D levels and insulin secretion and sensitivity.

Methods: This pilot study was conducted in a tertiary care Pediatric Emergency Department (ED). African American obese children (n = 29; 22 female) 13-17 y, with 25-hydroxy vitamin D level [25(OH)D] <20 ng/ml, were randomized to receive either 50,000 IU vitamin D/week or a placebo for 12 weeks. Pre- and post- oral glucose tolerance testing with glucose and insulin levels drawn at 0, 30, 60, 90 and 120 min were performed. Pre/post intervention lipid profiles and calcium levels were also evaluated.

Results: There was no difference in serum 25(OH)D between groups at baseline. Follow-up 25(OH)D level was greater in the treatment vs. placebo group, and significantly increased from baseline in the treatment group only. However, there was no difference between groups in baseline vs. follow-up insulin- or lipid-related parameters. Follow-up serum 25(OH)D was positively correlated with fasting insulin and high-density lipoprotein (HDL) level in the vitamin D treated group only.

Conclusion: While serum 25(OH)D levels in obese AA teens increased adequately with vitamin treatment for 12 weeks and correlated with fasting insulin, it did not significantly impact insulin secretion or sensitivity. Larger studies are required over a longer period of time to confirm and explore the reasons for this finding.

Citing Articles

Optimal vitamin D supplement dosage for improving insulin resistance in children and adolescents with overweight/obesity: a systematic review and network meta-analysis.

Zhu L, Li S, Zhong L, Xu S, Zhu H Eur J Nutr. 2023; 63(3):763-775.

PMID: 38160221 PMC: 10948536. DOI: 10.1007/s00394-023-03301-x.

The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review.

Calcaterra V, Verduci E, Vandoni M, Rossi V, Fiore G, Massini G Nutrients. 2022; 14(21).

PMID: 36364954 PMC: 9657567. DOI: 10.3390/nu14214692.

Adiposity Metabolic Consequences for Adolescent Bone Health.

Lopes K, Rodrigues E, da Silva Lopes M, do Nascimento V, Pott A, Avellaneda Guimaraes R Nutrients. 2022; 14(16).

PMID: 36014768 PMC: 9414751. DOI: 10.3390/nu14163260.

Vitamin D status and cardiometabolic risk factors in Greek adolescents with obesity - the effect of vitamin D supplementation: a pilot study.

Makariou S, Challa A, Siomou E, Tellis C, Tselepis A, Elisaf M Arch Med Sci Atheroscler Dis. 2020; 5:e64-e71.

PMID: 32529108 PMC: 7277522. DOI: 10.5114/amsad.2020.95569.

Vitamin D and Cardiovascular Risk: which Implications in Children?.

Savastio S, Pozzi E, Tagliaferri F, Degrandi R, Cinquatti R, Rabbone I Int J Mol Sci. 2020; 21(10).

PMID: 32429489 PMC: 7279000. DOI: 10.3390/ijms21103536.

References

Iraj B, Aminorroaya A, Amini M . Does the intramuscular injection of vitamin D increase insulin resistance?. J Res Pharm Pract. 2014; 1(2):60-5. PMC: 4076860. DOI: 10.4103/2279-042X.108372. View

Pirro M, Manfredelli M, Helou R, Scarponi A, Schillaci G, Bagaglia F . Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012; 19(10):924-31. DOI: 10.5551/jat.13128. View

Poomthavorn P, Saowan S, Mahachoklertwattana P, Chailurkit L, Khlairit P . Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics. Int J Obes (Lond). 2012; 36(4):491-5. DOI: 10.1038/ijo.2011.260. View

Ogden C, Carroll M, Kit B, Flegal K . Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014; 311(8):806-14. PMC: 4770258. DOI: 10.1001/jama.2014.732. View

Zeitz U, Weber K, Soegiarto D, Wolf E, Balling R, Erben R . Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003; 17(3):509-11. DOI: 10.1096/fj.02-0424fje. View

Boucher B, Mannan N, Noonan K, Hales C, Evans S . Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38(10):1239-45. DOI: 10.1007/BF00422375. View

Borissova A, Tankova T, Kirilov G, Dakovska L, Kovacheva R . The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003; 57(4):258-61. View

Matsuda M, DeFronzo R . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70. DOI: 10.2337/diacare.22.9.1462. View

Kelly A, Brooks L, Dougherty S, Carlow D, Zemel B . A cross-sectional study of vitamin D and insulin resistance in children. Arch Dis Child. 2011; 96(5):447-52. DOI: 10.1136/adc.2010.187591. View

10.

Le Floch J, Escuyer P, Baudin E, Baudon D, Perlemuter L . Blood glucose area under the curve. Methodological aspects. Diabetes Care. 1990; 13(2):172-5. DOI: 10.2337/diacare.13.2.172. View

11.

Ponda M, Huang X, Odeh M, Breslow J, Kaufman H . Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation. 2012; 126(3):270-7. PMC: 3713625. DOI: 10.1161/CIRCULATIONAHA.111.077875. View

12.

Keskin M, Kurtoglu S, Kendirci M, Atabek M, Yazici C . Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005; 115(4):e500-3. DOI: 10.1542/peds.2004-1921. View

13.

Alemzadeh R, Kichler J, Babar G, Calhoun M . Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008; 57(2):183-91. DOI: 10.1016/j.metabol.2007.08.023. View

14.

Kelishadi R, Salek S, Salek M, Hashemipour M, Movahedian M . Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr (Rio J). 2013; 90(1):28-34. DOI: 10.1016/j.jped.2013.06.006. View

15.

Reichel H, Koeffler H, Norman A . The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989; 320(15):980-91. DOI: 10.1056/NEJM198904133201506. View

16.

Harris S, Pittas A, Palermo N . A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab. 2012; 14(9):789-94. DOI: 10.1111/j.1463-1326.2012.01605.x. View

17.

Belenchia A, Tosh A, Hillman L, Peterson C . Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr. 2013; 97(4):774-81. DOI: 10.3945/ajcn.112.050013. View

18.

Gedik O, Akalin S . Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. 1986; 29(3):142-5. DOI: 10.1007/BF02427083. View

19.

Bikle D . Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev. 1992; 13(4):765-84. DOI: 10.1210/edrv-13-4-765. View

20.

. Executive summary: Standards of medical care in diabetes--2012. Diabetes Care. 2011; 35 Suppl 1:S4-S10. PMC: 3632178. DOI: 10.2337/dc12-s004. View